{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for pantothenic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
INN:zamerovimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03752398: Phase 1 Interventional Completed Melanoma (Excluding Uveal Melanoma)
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03287908: Phase 1 Interventional Terminated Relapsed/Refractory Multiple Myeloma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04701164: Phase 3 Interventional Completed Guillain-Barre Syndrome
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04194775: Phase 3 Interventional Active, not recruiting Hepatocellular Carcinoma
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pegloprastide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04406727: Phase 3 Interventional Not yet recruiting HIV-1 Infection
(2023)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03514121: Early Phase 1 Interventional Terminated Breast Cancer
(2018)
Source URL:
Class:
PROTEIN
